ST. MARYS HOSPITAL & MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $859K
- Transactions
- 156
- Companies
- 28
- Average per transaction
- $5,508
Who reported the payments
| AstraZeneca | $325,814 |
| Livanova USA, Inc. | $78,658 |
| Seagen Inc. | $73,741 |
| Mirati Therapeutics, Inc. | $69,119 |
| Pfizer | $58,069 |
| Novocure GmbH | $54,000 |
| Epizyme, Inc. | $46,898 |
| AbbVie | $37,074 |
| Astrazeneca UK Limited | $32,275 |
| Morphosys AG | $26,798 |
| Boston Scientific | $12,062 |
| Stryker | $10,574 |
| Insulet Corporation | $9,650 |
| Tandem Diabetes Care, Inc. | $5,700 |
| Smith+Nephew | $3,879 |
| Olympus America Inc. | $2,881 |
| Medline Industries LP | $2,500 |
| Fisher Scientific Company L.L.C. | $1,915 |
| Richard Wolf Medical Instruments Corp. | $1,719 |
| Medtronic | $1,700 |
| Merck | $1,116 |
| Teleflex LLC | $958 |
| Masimo Corporation | $827 |
| Aesculap, Inc. | $549 |
| Luminex Corporation | $414 |
| BD | $135 |
| Siemens Medical Solutions USA, Inc. | $115 |
| Baxter Healthcare | $64 |